Akari Therapeutics outlines 2025 progress in shareholder letter

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. ARGX
4. HD
5. SPY
6. KLAR
7. AMLX
8. METC
9. FN
10. TSLA

Go back to Akari Therapeutics outlines 2025 progress in shareholder letter
(NASDAQ: AKTX) Delayed: 7.55 +0.03 (0.40%)
Previous Close $7.52    52 Week High $19.75 
Open $7.30    52 Week Low $7.63 
Day High $7.79    P/E N/A 
Day Low $7.24    EPS $0.00 
Volume 94,847